NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
UNITED STATES |
OMB APPROVAL |
OMB Number: |
3235-0080 |
Expires: |
March 31, 2018 |
Estimated average burden |
hours per response: |
1.7 |
|
|
SECURITIES AND EXCHANGE COMMISSION |
Washington, D.C. 20549 |
FORM 25 |
NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
|
Commission File Number |
333-259250 |
|
(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
|
Address: |
4980 Carroll Canyon Road, Suite 100 |
|
San Diego |
CALIFORNIA |
92121 |
Telephone number: |
| 858-412-8151 |
|
(Address, including zip code, and telephone number, including area code, of Issuer's
principal executive offices)
|
Common stock |
(Description of class of securities)
|
|
Please place an X in the box to designate the rule provision relied upon to strike
the class of securities from listing and registration:
|
|
Pursuant to the requirements fo the Securities Exchange Act of 1934,
Nasdaq Stock Market LLC
certifies that it has reasonable grounds to believe that it
meets all of the requirements for filing the Form 25 and has caused this notification to be
signed on its behalf by the undersigned duly authorized person.
|
2024-06-28 |
By |
Aravind Menon |
|
Hearings Advisor |
Date |
|
Name |
Title |
|
1 |
Form 25 and attached Notice will be considered compliance with the provisions of
17 CFR 240.19d-1 as applicable. See General Instructions.
|
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
|
Delisting Determination, The Nasdaq Stock Market, LLC, June 28, 2024,
Cue Health Inc.
The Nasdaq Stock Market LLC (the Exchange) has determined to remove
from listing the securities of Cue Health Inc., effective at the opening
of the trading session on July 8, 2024.
Based on review of information provided by the Company, Nasdaq Staff
determined that the Company no longer qualified for listing on the
Exchange pursuant to Listing Rules 5101, 5110(b), IM-5101-1,
5250(c)(1), and 5450(a)(1)
The Company was notified of the Staff determination on May 28, 2024.
The Company did not appeal the Staff determination to the Hearings
Panel. The Company securities were suspended on June 6, 2024.
The Staff determination to delist the Company securities became
final on June 6, 2024.